Skip to main content

Table 1 Characteristics of patients

From: Randomized comparison of sevoflurane versus propofol-remifentanil on the cardioprotective effects in elderly patients with coronary heart disease

 

S (n = 60)

PR (n = 61)

P value

Age (years)

71.83 ± 3.56

71.95 ± 3.96

0.373

BMI(kg/m2)

23.26 ± 1.29

23.31 ± 1.18

0.286

Male / Female

12 / 48

15 / 46

0.544

ASA (II/III)

46/14

42/19

0.355

Pathological coronary artery (1/2/3)

33/26/1

38/21/2

0.769

Smoke

36(60.0)

28(45.9)

0.082

History of diabetes

48(80.0)

42(68.9)

0.160

Hypercholesterolemia

50(83.3)

46(75.4)

0.282

Duration of surgery (min)

300 [290,340]

300 [290,320]

0.050

Duration of anesthesia (min)

330 [320,380]

340 [320,350]

0.407

Recovery time (min)

13[11,16]

12[11,15]

0.445

Type of surgery

Pancreaticoduodenectomy

18(30.0)

31(50.8)

0.020

Radical cystectomy

42(70.0)

30(49.2)

0.020

Preoperative medication

Statins

57(95.0)

53(86.9)

0.121

β-blockers

17(28.3)

12(20.0)

0.264

ACEI

18(30.0)

13(21.3)

0.274

CCB

42(70.0)

45(73.8)

0.645

Insulin

46(76.7)

43(70.5)

0.441

nitrates

0(0)

2(3.3)

0.252

  1. BMI Body mass index, CCB calcium channel blocker, ACEI angiotensin-converting enzyme inhibitor
  2. Values were expressed as number (percentage), mean ± SD or median [interquartile ranges]
  3. Pathological coronary artery: the number of the diseased arteriosclerotic coronary artery vessels